QC Ops Tech II
Kite Pharma
Summary
Shift is Wednesday through Saturday 10 to 8:30 pm.
Job description
Job Description
Shift is Wednesday through Saturday 10 to 8:30 pm.
- Perform QC sample receipt, sample process, and sample distribution for testing and storage
- Perform Cryo sample transfer from -80C to LN2 storage
- Gather metric information for use in continuous improvement of areas of responsibility
- Perform 5s, Audit Checklist, and standard works in Lab
- Maintain Right the First Time
- Maintain "0" OSHA recordable goal in Lab
- Participate and support in ad-hoc projects or other duties as needed
- Shift hours are flexible within seven days each week
- Ability to lift 25 lbs and work with dry ice and LN2 freezers
- Additional duties as assigned
Basic Qualifications
- AA Degree with 1+ years of experience in pharmaceutical / biotechnology or similar manufacturing cGMP
- High School Degree with 2+ years of experience in pharmaceutical / biotechnology or similar manufacturing cGMP
- Ability to work overtime and holidays as needed
- Must have a strong work ethic and demonstrate dependability and timeliness
- Good interpersonal, verbal and written communication skills are essential in this collaborative work environment
- Comfortable in a fast-paced company environment with minimal direction and able to adjust workload based upon changing priorities
Requirements
- AA Degree with 1+ years of experience in pharmaceutical / biotechnology or similar manufacturing cGMP
- High School Degree with 2+ years of experience in pharmaceutical / biotechnology or similar manufacturing cGMP
- At least three years of QC Lab experience
- Ability to lift 25 lbs and work with dry ice and LN2 freezers
- Ability to work overtime and holidays as needed
- Strong work ethic, dependability, and timeliness
- Good interpersonal, verbal and written communication skills
- Comfortable in a fast-paced environment with minimal direction
Benefits
- Medical, Dental & Vision
- Life Insurance
- Paid Time Off
- Discretionary Annual Bonus
- Discretionary Stock-Based LTI
Company overview
Kite Pharma, Inc. is an American biotechnology company specializing in cancer immunotherapy with a primary focus on genetically engineered autologous CAR T cell therapy. Founded in 2009 and headquartered in Santa Monica, California, Kite was acquired by Gilead Sciences in 2017 for $11.9 billion. The company develops cell-based therapies that reengineer a patient's own immune cells to attack and fight cancer cells, representing a personalized approach to cancer treatment. Kite's lead product, Yescarta (axicabtagene ciloleucel), was the first CAR T therapy approved by the FDA for treating adult patients with relapsed or refractory large B-cell lymphoma. With approximately 2,000 employees and manufacturing facilities in California, Maryland, and the Netherlands, Kite operates as an independent company within Gilead Sciences while maintaining its singular focus on advancing cell therapy to treat and potentially cure cancer. The company's innovative approach represents a paradigm shift in cancer treatment, moving away from traditional pharmaceutical manufacturing to individualized cell therapies created one patient at a time.